Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection
| Autor: | Patrice Lefevre, Maurice Mongin, Philippe Hovette, Jean Marc Durand, Soumana Issifi |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment HIV Infections Dapsone Gastroenterology Autoimmune thrombocytopenia Autoimmune Diseases Leukocyte Count Acquired immunodeficiency syndrome (AIDS) Internal medicine Immunopathology medicine Humans Chemotherapy business.industry Platelet Count General Medicine Middle Aged medicine.disease Thrombocytopenic purpura Purpura Thrombocytopenic Immunology Female Viral disease Complication business medicine.drug |
| Zdroj: | The American journal of medicine. 90(6) |
| ISSN: | 0002-9343 |
| Popis: | purpose: The purpose of this study was to determine the effect of dapsone on platelet count in patients with human immunodeficiency virus (HIV)-related autoimmune thrombocytopenia. patients And Methods:Eleven patients with HIV-related thrombocytopenia received dapsone (50 to 125 mg/day) for 2 to 43 months. Patients with the acquired immunodeficiency syndrome were not enrolled. results: Of the 11 patients, six developed platelet counts above 50 × 10 9 /L and did not require any other specific therapy. No significant side effects were observed. conclusion: We conclude that dapsone may be effective in some patients with HIV-related thrombocytopenia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|